Private Trust Company’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $431K | Buy |
3,408
+107
| +3% | +$14.1K | 0.03% | 515 |
|
|
2026
Q1 | $460K | Buy |
3,301
+184
| +6% | +$25.8K | 0.04% | 467 |
|
|
2025
Q4 | $383K | Buy |
3,117
+221
| +8% | +$26.9K | 0.03% | 527 |
|
|
2025
Q3 | $321K | Sell |
2,896
-389
| -12% | -$44.2K | 0.03% | 567 |
|
|
2025
Q2 | $364K | Sell |
3,285
-576
| -15% | -$61.3K | 0.03% | 504 |
|
|
2025
Q1 | $433K | Sell |
3,861
-660
| -15% | -$68.1K | 0.04% | 439 |
|
|
2024
Q4 | $418K | Sell |
4,521
-340
| -7% | -$30.6K | 0.04% | 445 |
|
|
2024
Q3 | $408K | Sell |
4,861
-61
| -1% | -$4.66K | 0.04% | 459 |
|
|
2024
Q2 | $338K | Sell |
4,922
-1,555
| -24% | -$104K | 0.04% | 484 |
|
|
2024
Q1 | $474K | Buy |
6,477
+519
| +9% | +$39.9K | 0.05% | 376 |
|
|
2023
Q4 | $483K | Sell |
5,958
-23
| -0.4% | -$1.79K | 0.06% | 349 |
|
|
2023
Q3 | $448K | Buy |
5,981
+80
| +1% | +$6.15K | 0.06% | 340 |
|
|
2023
Q2 | $455K | Buy |
5,901
+545
| +10% | +$43.5K | 0.06% | 336 |
|
|
2023
Q1 | $444K | Sell |
5,356
-1,740
| -25% | -$144K | 0.06% | 332 |
|
|
2022
Q4 | $609K | Sell |
7,096
-138
| -2% | -$10.9K | 0.09% | 264 |
|
|
2022
Q3 | $446K | Buy |
7,234
+1,127
| +18% | +$71.1K | 0.07% | 294 |
|
|
2022
Q2 | $377K | Buy |
6,107
+383
| +7% | +$23.7K | 0.06% | 335 |
|
|
2022
Q1 | $340K | Sell |
5,724
-1,774
| -24% | -$113K | 0.05% | 281 |
|
|
2021
Q4 | $544K | Sell |
7,498
-220
| -3% | -$15.2K | 0.08% | 259 |
|
|
2021
Q3 | $539K | Buy |
7,718
+213
| +3% | +$15K | 0.08% | 259 |
|
|
2021
Q2 | $517K | Sell |
7,505
-723
| -9% | -$48.3K | 0.08% | 259 |
|
|
2021
Q1 | $531K | Buy |
8,228
+926
| +13% | +$59.7K | 0.09% | 250 |
|
|
2020
Q4 | $425K | Buy |
7,302
+2,501
| +52% | +$151K | 0.07% | 265 |
|
|
2020
Q3 | $303K | Buy |
4,801
+1,309
| +37% | +$90.8K | 0.06% | 289 |
|
|
2020
Q2 | $266K | Sell |
3,492
-1,691
| -33% | -$130K | 0.06% | 292 |
|
|
2020
Q1 | $387K | Buy |
5,183
+1,187
| +30% | +$82K | 0.1% | 237 |
|
|
2019
Q4 | $259K | Sell |
3,996
-5
| -0.1% | -$326 | 0.05% | 335 |
|
|
2019
Q3 | $253K | Buy |
4,001
+991
| +33% | +$64.8K | 0.05% | 316 |
|
|
2019
Q2 | $203K | Buy |
+3,010
| New | +$198K | 0.04% | 359 |
|
|
2018
Q4 | – | Sell |
-3,178
| Closed | -$245K | – | 360 |
|
|
2018
Q3 | $245K | Sell |
3,178
-553
| -15% | -$41.8K | 0.05% | 330 |
|
|
2018
Q2 | $264K | Buy |
3,731
+77
| +2% | +$5.44K | 0.06% | 315 |
|
|
2018
Q1 | $275K | Buy |
3,654
+61
| +2% | +$4.85K | 0.06% | 309 |
|
|
2017
Q4 | $257K | Sell |
3,593
-165
| -4% | -$12.5K | 0.05% | 316 |
|
|
2017
Q3 | $304K | Sell |
3,758
-853
| -18% | -$65.2K | 0.07% | 299 |
|
|
2017
Q2 | $326K | Sell |
4,611
-4,646
| -50% | -$309K | 0.07% | 290 |
|
|
2017
Q1 | $628K | Sell |
9,257
-3,855
| -29% | -$271K | 0.15% | 172 |
|
|
2016
Q4 | $938K | Sell |
13,112
-3,689
| -22% | -$274K | 0.22% | 108 |
|
|
2016
Q3 | $1.33M | Sell |
16,801
-8,789
| -34% | -$714K | 0.32% | 85 |
|
|
2016
Q2 | $2.13M | Buy |
25,590
+580
| +2% | +$51.5K | 0.56% | 49 |
|
|
2016
Q1 | $2.3M | Buy |
25,010
+147
| +0.6% | +$13.3K | 0.62% | 43 |
|
|
2015
Q4 | $2.52M | Buy |
24,863
+741
| +3% | +$77.1K | 0.72% | 34 |
|
|
2015
Q3 | $2.37M | Buy |
24,122
+16,673
| +224% | +$1.85M | 0.71% | 34 |
|
|
2015
Q2 | $871K | Sell |
7,449
-47
| -0.6% | -$5.14K | 0.25% | 115 |
|
|
2015
Q1 | $735K | Buy |
7,496
+2,409
| +47% | +$245K | 0.21% | 131 |
|
|
2014
Q4 | $479K | Buy |
5,087
+93
| +2% | +$9.62K | 0.15% | 177 |
|
|
2014
Q3 | $532K | Buy |
4,994
+224
| +5% | +$21.9K | 0.18% | 134 |
|
|
2014
Q2 | $395K | Buy |
4,770
+1,612
| +51% | +$125K | 0.13% | 186 |
|
|
2014
Q1 | $224K | Buy |
3,158
+504
| +19% | +$39.5K | 0.08% | 234 |
|
|
2013
Q4 | $199K | Buy |
2,654
+372
| +16% | +$25.9K | 0.08% | 223 |
|
|
2013
Q3 | $143K | Sell |
2,282
-194
| -8% | -$11.6K | 0.06% | 249 |
|
|
2013
Q2 | $127K | Buy |
+2,476
| New | +$129K | 0.06% | 250 |
|
Other funds holding GILD
Private Trust Company's GILD Position: Q2 2026 in Review
Private Trust Company increased its Gilead Sciences (GILD) stake by 3.2% in Q2 2026, buying an estimated $14.1K and bringing the position to 3,408 shares worth $431K. The position accounts for 0.03% of the portfolio, ranked #515.
Private Trust Company first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. The position peaked at $2.52M in Q4 2015. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Private Trust Company held 3,408 shares of Gilead Sciences worth $431K as of Q2 2026.
- Private Trust Company bought 107 Gilead Sciences shares in Q2 2026, an estimated $14.1K.
- Gilead Sciences made up 0.03% of Private Trust Company's portfolio in Q2 2026, its #515 holding.
- Private Trust Company first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
- Private Trust Company's Gilead Sciences position peaked at $2.52M in Q4 2015.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Private Trust Company's 13F filing for Q2 2026, filed 28 Jul 2026.